Premium
Efficacy of cytapheresis for remission induction and dermatological manifestations of ulcerative colitis
Author(s) -
Nomura Osamu,
Osada Taro,
Shibuya Tomoyoshi,
Ishikawa Dai,
Haga Keiichi,
Kodani Tomohiro,
Sakamoto Naoto,
Ogihara Tatsuo,
Yamaji Ken,
Watanabe Sumio
Publication year - 2018
Publication title -
journal of clinical apheresis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.697
H-Index - 46
eISSN - 1098-1101
pISSN - 0733-2459
DOI - 10.1002/jca.21555
Subject(s) - medicine , concomitant , prednisolone , gastroenterology , ulcerative colitis , surgery , disease
Background In ulcerative colitis (UC) patients, cytapheresis depletes elevated and activated leucocytes, which are known to release inflammatory cytokines including tumor necrosis factor (TNF)‐α. Further, there are UC patients who develop erythema nodosum (EN) or pyoderma gangrenosum (PG) as extra‐intestinal manifestations of UC. Methods Between 2008 and 2015, 181 consecutive patients with active UC received cytapheresis with either a granulocyte and monocyte apheresis (GMA) column or with a leucocyte removal filter (LCAP) as remission induction therapy. Each patient received weekly or intensive (2‐3 sessions/week) cytapheresis up to 10 sessions. In 13 patients, UC was complicated by EN or PG. Lichtiger's clinical activity index (CAI) ≤4 meant remission, while ≥3 decrease in CAI meant response to therapy. Prednisolone sparing and the changes in the extra‐intestinal manifestations were factored for assessing treatment efficacy. Results The overall remission and response rates were 52.5% and 71.8%, respectively, CAI fell from 9.4 ± 3.3 to 4.9 ± 3.5 ( P < 0.001). The efficacy rates in subgroups on concomitant corticosteroid, anti‐TNF or tacrolimus, and those without concomitant medications were not significantly different ( P > 0.05). However, in 84 patients on prednisolone, the average daily prednisolone dose was reduced from 18.15 to 12.43 mg/day ( P < 0.001) with 21.7% being corticosteroid free. All patients with EN or PG showed favorable response to cytapheresis, notably 2 EN patients achieving remission after just 2 cytapheresis sessions without concomitant medication. Conclusions In this retrospective efficacy evaluation, cytapheresis was effective as remission induction therapy with steroid sparing effect and desirable safety profile. Further, patients with EN or PG responded favorably to cytapheresis.